| Cox proportional hazard regression | |||||
---|---|---|---|---|---|---|
Lymph node negative (n=121) | Lymph node positive (n=90) | |||||
HR | 95% CI | P value | HR | 95% CI | P value | |
Recurrence | Â | Â | Â | Â | Â | Â |
ER/PR negativitya | 2.06 | 0.80-5.31 | 0.136 | 0.62 | 0.30-0.62 | 0.202 |
Age | 1.01 | 0.96-1.05 | 0.788 | 1.01 | 0.98-1.01 | 0.582 |
BMI | 0.95 | 0.84-1.08 | 0.450 | 1.02 | 0.92-1.02 | 0.703 |
Combined therapyb | 2.02 | 0.83-4.93 | 0.120 | 2.12 | 0.85-5.29 | 0.107 |
APOA1 rs670 A/Ac | 4.98 | 1.40-17.70 | 0.013 | 2.46 | 0.86-2.46 | 0.093 |
Mortality | Â | Â | Â | Â | Â | Â |
ER/PR negativitya | 0.24 | 0.05-1.08 | 0.064 | 0.52 | 0.22-1.18 | 0.118 |
Age | 1.05 | 0.98-1.13 | 0.196 | 1.02 | 0.99-1.06 | 0.262 |
BMI | 0.89 | 0.71-1.11 | 0.296 | 1.03 | 0.91-1.16 | 0.648 |
Combined therapyb | 1.83 | 0.41-8.18 | 0.430 | 2.65 | 0.89-7.88 | 0.081 |
APOA1 rs670 A/Ac | 9.87 | 1.60-60.81 | 0.014 | 2.86 | 0.96-8.55 | 0.060 |